BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 31077988)

  • 1. Advantages and shortcomings of cell-based electrical impedance measurements as a GPCR drug discovery tool.
    Doijen J; Van Loy T; Landuyt B; Luyten W; Schols D; Schoofs L
    Biosens Bioelectron; 2019 Jul; 137():33-44. PubMed ID: 31077988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparing label-free biosensors for pharmacological screening with cell-based functional assays.
    Peters MF; Vaillancourt F; Heroux M; Valiquette M; Scott CW
    Assay Drug Dev Technol; 2010 Apr; 8(2):219-27. PubMed ID: 20085460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Real-time monitoring of morphological changes in living cells by electronic cell sensor arrays: an approach to study G protein-coupled receptors.
    Yu N; Atienza JM; Bernard J; Blanc S; Zhu J; Wang X; Xu X; Abassi YA
    Anal Chem; 2006 Jan; 78(1):35-43. PubMed ID: 16383308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Label-free impedance-based whole cell assay to study GPCR pharmacology.
    Doornbos MLJ; Heitman LH
    Methods Cell Biol; 2019; 149():179-194. PubMed ID: 30616818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New paradigms in GPCR drug discovery.
    Jacobson KA
    Biochem Pharmacol; 2015 Dec; 98(4):541-55. PubMed ID: 26265138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Label-free whole-cell assays: expanding the scope of GPCR screening.
    Scott CW; Peters MF
    Drug Discov Today; 2010 Sep; 15(17-18):704-16. PubMed ID: 20601093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An overview of Ca
    Ma Q; Ye L; Liu H; Shi Y; Zhou N
    Expert Opin Drug Discov; 2017 May; 12(5):511-523. PubMed ID: 28277837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Label-free optical biosensor: a tool for G protein-coupled receptors pharmacology profiling and inverse agonists identification.
    Lee PH
    J Recept Signal Transduct Res; 2009; 29(3-4):146-53. PubMed ID: 19594401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mining the potential of label-free biosensors for seven-transmembrane receptor drug discovery.
    Rocheville M; Martin J; Jerman J; Kostenis E
    Prog Mol Biol Transl Sci; 2013; 115():123-42. PubMed ID: 23415093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent progress in assays for GPCR drug discovery.
    Guo S; Zhao T; Yun Y; Xie X
    Am J Physiol Cell Physiol; 2022 Aug; 323(2):C583-C594. PubMed ID: 35816640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell-impedance-based label-free technology for the identification of new drugs.
    Lundstrom K
    Expert Opin Drug Discov; 2017 Apr; 12(4):335-343. PubMed ID: 28276704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Label-free biosensor assays in GPCR screening.
    Grundmann M; Kostenis E
    Methods Mol Biol; 2015; 1272():199-213. PubMed ID: 25563186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monitoring the Reversibility of GPCR Signaling by Combining Photochromic Ligands with Label-free Impedance Analysis.
    Wirth U; Erl J; Azzam S; Höring C; Skiba M; Singh R; Hochmuth K; Keller M; Wegener J; König B
    Angew Chem Int Ed Engl; 2023 May; 62(21):e202215547. PubMed ID: 36932995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Illuminating the complexity of GPCR pathway selectivity - advances in biosensor development.
    Wright SC; Bouvier M
    Curr Opin Struct Biol; 2021 Aug; 69():142-149. PubMed ID: 34048988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impedance responses reveal β₂-adrenergic receptor signaling pluridimensionality and allow classification of ligands with distinct signaling profiles.
    Stallaert W; Dorn JF; van der Westhuizen E; Audet M; Bouvier M
    PLoS One; 2012; 7(1):e29420. PubMed ID: 22242170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tools for GPCR drug discovery.
    Zhang R; Xie X
    Acta Pharmacol Sin; 2012 Mar; 33(3):372-84. PubMed ID: 22266728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A study of the dopamine transporter using the TRACT assay, a novel in vitro tool for solute carrier drug discovery.
    Sijben HJ; van den Berg JJE; Broekhuis JD; IJzerman AP; Heitman LH
    Sci Rep; 2021 Jan; 11(1):1312. PubMed ID: 33446713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. History of the G protein-coupled receptor (GPCR) assays from traditional to a state-of-the-art biosensor assay.
    Miyano K; Sudo Y; Yokoyama A; Hisaoka-Nakashima K; Morioka N; Takebayashi M; Nakata Y; Higami Y; Uezono Y
    J Pharmacol Sci; 2014; 126(4):302-9. PubMed ID: 25421710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced selectivity screening of GPCR ligands using a label-free cell based assay technology.
    McGuinness RP; Proctor JM; Gallant DL; van Staden CJ; Ly JT; Tang FL; Lee PH
    Comb Chem High Throughput Screen; 2009 Sep; 12(8):812-23. PubMed ID: 19531008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Label-free cell-based assays for GPCR screening.
    Fang Y; Frutos AG; Verklereen R
    Comb Chem High Throughput Screen; 2008 Jun; 11(5):357-69. PubMed ID: 18537557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.